tradingkey.logo
tradingkey.logo
Search

Unitedhealth Group Inc

UNH
Add to Watchlist
425.360USD
-1.590-0.37%
Close 07/02, 13:00ETQuotes delayed by 15 min
386.23BMarket Cap
31.99P/E TTM

TradingKey Stock Score of Unitedhealth Group Inc

Currency: USD Updated: 2026-07-02

Key Insights

Unitedhealth Group Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 53 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 410.16.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Unitedhealth Group Inc's Score

Industry at a Glance

Industry Ranking
53 / 75
Overall Ranking
236 / 4565
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

47°C

Very Low
Very High
Positive

Unitedhealth Group Inc Highlights

StrengthsRisks

UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.

Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 447.93B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.62% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 52.29%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 52.29%.
Overvalued
The company’s latest PE is 31.99, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 771.23M shares, decreasing 0.47% quarter-over-quarter.
Held by Ruane Cunniff
Star Investor Ruane Cunniff holds 513.27K shares of this stock.

Analyst Rating

Based on 30 analysts
Buy
Current Rating
410.163
Target Price
-3.84%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Unitedhealth Group Inc?

The TradingKey Stock Score provides a comprehensive assessment of Unitedhealth Group Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Unitedhealth Group Inc’s performance and outlook.

How do we generate the financial health score of Unitedhealth Group Inc?

To generate the financial health score of Unitedhealth Group Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Unitedhealth Group Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Unitedhealth Group Inc.

How do we generate the company valuation score of Unitedhealth Group Inc?

To generate the company valuation score of Unitedhealth Group Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Unitedhealth Group Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Unitedhealth Group Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Unitedhealth Group Inc.

How do we generate the earnings forecast score of Unitedhealth Group Inc?

To calculate the earnings forecast score of Unitedhealth Group Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Unitedhealth Group Inc’s future.

How do we generate the price momentum score of Unitedhealth Group Inc?

When generating the price momentum score for Unitedhealth Group Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Unitedhealth Group Inc’s prices. A higher score indicates a more stable short-term price trend for Unitedhealth Group Inc.

How do we generate the institutional confidence score of Unitedhealth Group Inc?

To generate the institutional confidence score of Unitedhealth Group Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Unitedhealth Group Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Unitedhealth Group Inc.

How do we generate the risk management score of Unitedhealth Group Inc?

To assess the risk management score of Unitedhealth Group Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Unitedhealth Group Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Unitedhealth Group Inc.